Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christina Bright (NPI 1063684934)

Field	Value
Entity Type	Individual
Organization	Christina Bright
Address	1501 Ne Medical Center Dr
City	Bend
State	OR
ZIP	97701
Taxonomy	Rheumatology Physician
NPI Enumerated	March 31, 2008

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused rheumatology practice: total Medicare revenue is $1.4M while Medicaid shows none (no Medicaid billing on file), indicating a single‑payer footprint in the available data rather than a dual‑payer mix. The absence of Medicaid billing suggests payers and utilization patterns should be interpreted primarily through the Medicare lens for competitive or network decisions.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 55.7% of this provider's total Medicare revenue, with J2350, J0129, and J0897 together forming the bulk of payments. Such concentration means a small set of biologic injectables drives most Medicare revenue for this clinician rather than office visits or ancillary services.

The code mix and descriptions show this is an infusion/biologic administration–heavy operation: leading codes are J2350 (injection, ocrelizumab), J0129 (injection, abatacept), and J0897 (injection, denosumab), and multiple infusion and chemotherapy administration CPTs appear on the file (96413, 96365, 96415). Presence of many drug-infusion HCPCS plus on-site labs (85025, 80076, 82306) indicates the practice delivers and bills for in-office biologic infusions and supporting laboratory monitoring.

Competitive standing across individual codes is mixed. For the largest revenue code J2350 the provider ranks #77 of 105 providers nationally (25th percentile), a modest position by national volume standards, while J0897 ranks #997 of 10057 (90th percentile) indicating relatively strong national activity for denosumab; other infusion agents such as J1745 rank at the 85th percentile, showing above-typical volume for those specific biologics.

There are several statistically notable outliers that shape the competitive profile: J3489 (zoledronic acid) is labeled an extreme outlier, ranking #26 of 3032 providers nationally (99th percentile), and non-procedural E/M and infusion-add on codes are also elevated — 99214 ranks #14603 of 479517 (97th percentile) and 96415 ranks #172 of 4959 (97th percentile). These flags suggest unusually high volumes for specific infusions and follow-up visit complexity relative to national peers.

Operational detail visible in the claims mix: high claim counts with low per-claim payments exist for some items (for example, J3262 shows 31.4K claims at $5 avg paid/claim totaling $156.8K), whereas other biologics generate substantial revenue per claim (for example, J2350 totaling $396K at $44 avg paid/claim). This pattern is consistent with a practice that administers a large number of low-unit-value drugs alongside a smaller set of higher-revenue biologics.

Clinical support services are embedded in billing: routine lab panels and monitoring codes appear in the top codes list (85025, 80076, 82306, 86140, 82565, 80053), which aligns with chronic biologic therapy management requiring periodic labs. The presence of these lab codes alongside frequent infusion administration underscores an integrated infusion-and-monitoring practice model rather than a pure consultation-only rheumatology practice.

The provider has long tenure in the NPI file, enumerated 2008-03-31 (~18 years ago), which supports interpretation of these utilization patterns as established rather than transient. For payers and network planners, that tenure combined with a concentrated biologics revenue base and Medicaid absence frames this clinician as an established, Medicare-centric biologic/infusion provider with focused competitive strengths on a few high-volume injectable therapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

45 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	9,000	$40	$396K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	6,300	$30	$214.2K
J0897	Injection, denosumab, 1 mg	10,860	$20	$195.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,960	$30	$181K
J3262	Injection, tocilizumab, 1 mg	31,360	$10	$156.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	910	$90	$77.9K
J1602	Injection, golimumab, 1 mg, for intravenous use	6,400	$10	$70.4K
J3111	Injection, romosozumab-aqqg, 1 mg	6,510	$10	$52.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	250	$100	$23.5K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	410	$50	$18.7K

Showing 1–10 of 45

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Christina Bright — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

45 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	2	10	14,100	$40	$605.4K
J0129	11	20	6,300	$30	$260.7K
J3262	7	10	31,180	$1	$176.4K
J1602	21	20	13,600	$10	$156.4K
J1745	5	20	3,750	$30	$115.2K
J3111	5	10	12,710	$10	$107K
J0897	8	70	2,400	$20	$78.3K
96413	19	90	150	$100	$18.2K
99214	51	6,070	80	$70	$10.3K
99215	1,409	2,170	40	$100	$6.7K

Showing 1–10 of 45

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christina Bright, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bend Memorial Clinic PC	OR	Family Medicine Physician	$0	$11.7M
Anthony Kahr	OR	Rheumatology Physician	$2.8M	$0
Laith Kadasi	OR	Ophthalmology Physician	$2.2M	$0
Gregory Borstad	NC	Rheumatology Physician	$1.6M	$0
William Schmidt	OR	Hematology & Oncology Physician	$1.4M	$0
Benjamin Miriovsky	AL	Hematology & Oncology Physician	$1.3M	$0
Adam Williams	OR	Allergy & Immunology Physician	$1.3M	$0
David Greenberg	OR	Diagnostic Radiology Physician	$997.3K	$0
Wayne Nelson	OR	Vascular Surgery Physician	$611.9K	$0
Rahim Fazel	OR	Diagnostic Radiology Physician	$574.6K	$0

Nearby Providers

Other providers in the same ZIP code as Christina Bright, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ortc, LLC	OR	Substance Abuse Rehabilitation Facility	$747.3K	$16.2M
Telecare Mental Heatlh Service Of Oregon, Inc	OR	Mental Illness Community Based Residential Treatment Facility	$0	$12.8M
Pfeifer & Associates	OR	Community/Behavioral Health Agency	$0	$11.6M
Grants Pass Treatment Center	OR	Substance Abuse Rehabilitation Facility	$0	$9.5M
St. Charles Health System, Inc.	OR	Family Medicine Physician	$0	$8.6M
Deschutes County Oregon	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$7.9M
Central Oregon Pediatric Associates	OR	Pediatrics Physician	$0	$7.2M
Bend Surgery Center LLC	OR	Ambulatory Surgical Clinic/Center	$4.8M	$1.7M
Adam Angeles	OR	Plastic and Reconstructive Surgery Physician	$6.5M	$0
Central Oregon Emergency Physicians LLC	OR	Emergency Medical Services (Emergency Medicine) Physician	$0	$5.2M

Christina Bright — Billing Profile & Reimbursement Data

Sign up for Christina Bright — Billing Profile & Reimbursement Data policy alerts

Christina Bright — Billing Profile & Reimbursement Data

Sign up for Christina Bright — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References